|
ATXN7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.90880000000049E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.89819999999652E-05 |
| Normal-vs-Stage2 |
8.209500E-02 |
| Normal-vs-Stage3 |
3.70619999999766E-05 |
| Normal-vs-Stage4 |
1.224530E-04 |
| Stage1-vs-Stage2 |
5.310000E-01 |
| Stage1-vs-Stage3 |
3.665000E-01 |
| Stage1-vs-Stage4 |
1.790590E-01 |
| Stage2-vs-Stage3 |
2.778200E-01 |
| Stage2-vs-Stage4 |
1.863600E-01 |
| Stage3-vs-Stage4 |
4.380600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.24460000000293E-05 |
| Normal-vs-AfricanAmerican |
1.098160E-03 |
| Normal-vs-Asian |
4.124600E-03 |
| Caucasian-vs-AfricanAmerican |
7.484800E-01 |
| Caucasian-vs-Asian |
4.837600E-01 |
| AfricanAmerican-vs-Asian |
4.520400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.54929999951881E-07 |
| Normal-vs-Female |
3.594400E-02 |
| Male-vs-Female |
4.198500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.50980000000112E-05 |
| Normal-vs-Extreme_Weight |
3.7409999997795E-07 |
| Normal-vs-Obese |
1.559810E-03 |
| Normal-vs-Extreme_Obese |
4.242700E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.103600E-01 |
| Normal_Weight-vs-Obese |
2.623600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.644000E-01 |
| Extreme_Weight-vs-Obese |
6.320200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.399400E-01 |
| Obese-vs-Extreme_Obese |
6.196200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.031600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.140950E-03 |
| Normal-vs-Age(61-80Yrs) |
1.88245999999115E-05 |
| Normal-vs-Age(81-100Yrs) |
3.52590000000097E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.378600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.185000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.540320E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.261040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.179840E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.037200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.76319999999741E-05 |
| Normal-VS-Type2 PRCC |
1.29560000505791E-08 |
| Normal-VS-KIRP CIMP |
3.034000E-01 |
| Normal-VS-Unclassified PRCC |
5.150100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.236900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.413410E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.163400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.324200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.097900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.316600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.45159995135202E-09 |
| Normal-vs-N1 |
4.788200E-04 |
| Normal-vs-N2 |
1.131650E-02 |
| N0-vs-N1 |
7.796200E-02 |
| N0-vs-N2 |
8.085800E-01 |
| N1-vs-N2 |
3.570000E-01 |
|
|
